Price $112.31 |
Market Cap
35.52B
|
Sector Health Care |
Div. Growth
8.00%
|
|
P/E
26.5
|
P/B
6.16
|
P/S
5.06
|
Dividend %
0.70%
|
|
P/CF
-
|
P/FCF
38.6
|
Op. Cash Flow
1.47M
|
FCF
3.1
|
|
Op. Margin
24.00%
|
Net Margin
19.20%
|
ROE
24.80%
|
ROI
16.90%
|
|
ROA
12.60%
|
EPS Growth
8.60%
|
Current Ratio
2.0
|
Debt/Equity
51.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals PLC (JAZZ) | $131.85 | - | - | 7.93B | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.19 | - | - | 126.6M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.10 | - | - | 4.7M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.14 | - | - | 12.3M | Strong Buy |
| PAVmed Inc (PAVM) | $0.34 | - | - | 42.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
